LDK378
Ceritinib is an orally available inhibitor of the receptor tyrosine kinase activity of anaplastic lymphoma kinase (ALK) with antineoplastic activity.
Product Specifications
CAS Number
1032900-25-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
558.14
Molecular Formula
C28H36ClN5O3S
Notes
Research use only, not for human use.
Receptor
ALK| FLT3| IGF-1R| Insulin Receptor| STK22D
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6135021-01 0.1 mL
AVPR1A (Vasopressin V1a Receptor, V1aR, VPR V1a, Antidiuretic Hormone Receptor 1a, Vascular/Hepatic-type Arginine Vasopressin Receptor, AVPR1) APC
Ask
View Details MBS6135021-02 5x 0.1 mL
AVPR1A (Vasopressin V1a Receptor, V1aR, VPR V1a, Antidiuretic Hormone Receptor 1a, Vascular/Hepatic-type Arginine Vasopressin Receptor, AVPR1) APC
Ask
View Details